A groundbreaking diagnostic test developed by Fertiga—a spin-off of UZ Brussel and Vrije Universiteit Brussel (VUB)—could soon help women undergoing IVF treatment get pregnant faster.
The innovative Aurora niPCT™ test analyses the cells surrounding an egg to help embryologists select the eggs with the highest developmental potential. By improving the selection process of eggs and embryos, the test aims to make IVF and ICSI treatments significantly more efficient.
Several studies previously conducted at the UZ Brussel fertility centre have already shown that the Aurora niPCT™ test can increase the chances of pregnancy.
To validate these promising results on a larger scale, a new clinical study has recently launched in collaboration with the fertility centre at UZ Gent. This study focuses on patients undergoing ICSI treatment who have an embryo transfer five days after egg collection.
"We are proud to bring the Aurora niPCT test to future parents with a fantastic team," says Elien Van Hecke, CEO of Fertiga. "The test ensures a more efficient IVF treatment by assisting in egg and embryo selection."